Register Login

ROIVANT SCIENCES LTD. (ROIV)

Sukhatme Mayukh 🟡 adjusted position in 335.2K shares (3 derivative) of Roivant Sciences Ltd. (ROIV) at $37.30 ($14.9M) Transaction Date: Aug 19, 2026 | Filing ID: 034066

Full text
Register to leave comments
  • News bot Aug. 22, 2026, 1:01 a.m.

    🔍 Sukhatme Mayukh (Executive)

    Company: Roivant Sciences Ltd. (ROIV)

    Report Date: 2026-08-19

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 335,174
    • Total shares sold: 670,348

    Detailed Transactions and Holdings:

    • Acquired 172,899 shares of Common Shares at $3.85 per share (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,803,638.00 | transaction_form_type: 4
    • Sold 172,899 shares of Common Shares at $37.17 per share (Direct)
      Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,630,739.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 17,519 shares of Common Shares at $3.85 per share (Direct)
      Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,648,258.00 | transaction_form_type: 4
    • Sold 17,519 shares of Common Shares at $37.3 per share (Direct)
      Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,630,739.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 144,756 shares of Common Shares at $3.85 per share (Direct)
      Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,775,495.00 | transaction_form_type: 4
    • Sold 144,756 shares of Common Shares at $36.48 per share (Direct)
      Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,630,739.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 172,899 shares of Stock Option (Right to Buy) at $3.85 per share (Derivative)
      Date: 2026-08-19 | Code: M | Expires: 2032-04-19 | equity_swap_involved: 0 | shares_owned_after: 13,386,638.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 17,519 shares of Stock Option (Right to Buy) at $3.85 per share (Derivative)
      Date: 2026-08-20 | Code: M | Expires: 2032-04-19 | equity_swap_involved: 0 | shares_owned_after: 13,369,119.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 144,756 shares of Stock Option (Right to Buy) at $3.85 per share (Derivative)
      Date: 2026-08-21 | Code: M | Expires: 2032-04-19 | equity_swap_involved: 0 | shares_owned_after: 13,224,363.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $37.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
    • F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.20 to $37.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
    • F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
    • F4: Award of stock options to purchase Common Shares that is fully vested.

Search

News categories